BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 16777405)

  • 1. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging in multiple myeloma.
    Delorme S; Baur-Melnyk A
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging patients with myeloma.
    Winterbottom AP; Shaw AS
    Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA; Nguyen BD
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma update.
    Mulligan ME
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imaging methods in diagnosis and monitoring of multiple myeloma].
    Myslivecek M; Nekula J; Bacovský J
    Vnitr Lek; 2006 Nov; 52 Suppl 2():46-54. PubMed ID: 18175429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
    Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
    Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
    Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
    Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern imaging of multiple myeloma.
    Seppanen M
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
    Truong MT; Munden RF; Movsas B
    J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MRI for the diagnosis and prognosis of multiple myeloma.
    Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
    Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
    Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification, staging and prognostic indices for multiple myeloma].
    Hotta T
    Nihon Rinsho; 2007 Dec; 65(12):2161-6. PubMed ID: 18069256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
    Kasamon YL; Jones RJ; Wahl RL
    J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.